| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |